Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

March 7, 2025

Study Completion Date

March 7, 2025

Conditions
Healthy
Interventions
DRUG

MDMA 120 mg + MDMA 60 mg

An oral dose of 120 mg racemic MDMA will be administered followed by a second dose of 60 mg racemic MDMA two hours later.

DRUG

MDMA 120 mg + placebo

An oral dose of 120 mg racemic MDMA will be administered followed by a placebo two hours later.

DRUG

Placebo

An oral placebo will be administered followed by a placebo two hours later.

Trial Locations (1)

4031

University Hospital, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT05809271 - Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose | Biotech Hunter | Biotech Hunter